7 September 2021
Dermatology Life Quality Index (DLQI) App Launched
The free app gives an instant DLQI score and will help people to keep track of how psoriasis impacts their quality of life.
-
-
3 September 2021
Cosentyx (Secukinumab) - NICE approves biologic to treat psoriasis in children and young people
Cosentyx (Secukinumab) has been recommended for the treatment of severe psoriasis in children and young people (aged 6 to 17 years) in England and Wales.
-
1 September 2021
Bimzelx (Bimekizumab) - NICE approves new biologic for psoriasis
Bimzelx (Bimekizumab) has been recommended for the treatment of severe psoriasis in adults in England and Wales.
-
19 August 2021
Coronavirus (COVID-19) Information
Information for people living with psoriasis and psoriatic arthritis, including those taking immunosuppressive medicines.
-
19 August 2021
What is the latest 'shielding' guidance?
Advice for people who are deemed to be 'clinically extremely vulnerable'.